Variant report
Variant | nsv1027575 |
---|---|
Chromosome Location | chr7:125395345-125429650 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:5)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr7:125384743..125387377-chr7:125395816..125398229,2 | K562 | blood: | |
2 | chr7:125425665..125427173-chr7:125429693..125431589,2 | K562 | blood: | |
3 | chr7:125391124..125394118-chr7:125397604..125400061,2 | K562 | blood: | |
4 | chr7:125414524..125416692-chr7:125417841..125420169,2 | K562 | blood: | |
5 | chr7:125414524..125416692-chr7:125417841..125420169,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs190643369 | chr7:125412474-125412475 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs544737805 | chr7:125412495-125412496 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs199942351 | chr7:125412570-125412571 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs564911128 | chr7:125412578-125412579 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs76561036 | chr7:125412626-125412627 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs548916089 | chr7:125412629-125412630 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs560763795 | chr7:125412672-125412673 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs373806859 | chr7:125412690-125412691 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs567502841 | chr7:125412703-125412704 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs182932409 | chr7:125412785-125412786 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs549493726 | chr7:125412889-125412890 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs187658102 | chr7:125412902-125412903 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs530399070 | chr7:125412907-125412908 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs538414682 | chr7:125412914-125412915 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs79912500 | chr7:125412917-125412918 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs150235304 | chr7:125412939-125412940 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs199748017 | chr7:125412953-125412954 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs201987089 | chr7:125412954-125412955 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs370397702 | chr7:125412955-125412956 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs182844809 | chr7:125412956-125412957 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs201901881 | chr7:125412996-125412997 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs199846030 | chr7:125413006-125413007 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs576390667 | chr7:125413011-125413012 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs1859190 | chr7:125413014-125413015 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs112055323 | chr7:125413015-125413016 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs559063243 | chr7:125413112-125413113 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs577430977 | chr7:125413171-125413172 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs541597919 | chr7:125413175-125413176 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs559991435 | chr7:125413211-125413212 | Flanking Active TSS Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs372170412 | chr7:125413253-125413254 | Flanking Active TSS Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs115839107 | chr7:125413260-125413261 | Flanking Active TSS Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs187521485 | chr7:125413267-125413268 | Flanking Active TSS Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs560918533 | chr7:125413295-125413296 | Flanking Active TSS Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs67477800 | chr7:125413309-125413310 | Flanking Active TSS Active TSS Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs543030029 | chr7:125413339-125413340 | Flanking Active TSS Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs147928049 | chr7:125413345-125413346 | Flanking Active TSS Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs372211042 | chr7:125413412-125413413 | Flanking Active TSS Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs376531764 | chr7:125413476-125413477 | Flanking Active TSS Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs6977436 | chr7:125413486-125413487 | Flanking Active TSS Active TSS Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs565779503 | chr7:125413493-125413494 | Flanking Active TSS Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs529984492 | chr7:125413532-125413533 | Flanking Active TSS Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs114247242 | chr7:125413538-125413539 | Flanking Active TSS Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs141279389 | chr7:125413562-125413563 | Flanking Active TSS Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs193166489 | chr7:125413580-125413581 | Flanking Active TSS Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs559000793 | chr7:125413592-125413593 | Flanking Active TSS Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs570910220 | chr7:125413604-125413605 | Active TSS Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
47 | rs146951791 | chr7:125413613-125413614 | Active TSS Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
48 | rs553517299 | chr7:125413633-125413634 | Active TSS Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
49 | rs552352934 | chr7:125413672-125413673 | Active TSS Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
50 | rs574962013 | chr7:125413676-125413677 | Active TSS Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Melanoma | 18172304 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 22495311 | CNVD |
Wilms tumour | 21544195 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Low-grade fibromyxoid sarcoma | 0 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 21264507 | CNVD |
Shwachman-Diamond syndrome | 22934832 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Cutaneous malignant melanoma | 17690212 | CNVD |
Leukemia | 17361228 | CNVD |
Breast cancer | 16461572 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Malignant melanoma | 17690212 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
abortions and stillbirths | 19751515 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Lung cancer | 18438408 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Prostate cancer | 16573809 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Biliary cancer | 19435499 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Prostate cancer | 23792589 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Non-small cell lung cancer | 19889201 | CNVD |
Acute myeloid leukemia | 18000384 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Metastatic melanoma | 18483359 | CNVD |
Autism | 18414403 | CNVD |
Autism | 19401682 | CNVD |
Autism | 19546859 | CNVD |
Schizophrenia | 19546859 | CNVD |
Tourette syndrome | 19546859 | CNVD |
Melanoma | 19188590 | CNVD |
Hepatocellular carcinoma | 16785998 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Breast cancer | 21509527 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Epilepsy | 21635232 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
abnormal development | 18461090 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Autism | 20858243 | CNVD |
Autism | 20808228 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:125412400-125413200 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
2 | chr7:125412400-125413800 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
3 | chr7:125412600-125413400 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
4 | chr7:125412800-125413200 | Enhancers | ES-WA7 Cell Line | embryonic stem cell |
5 | chr7:125413000-125413800 | Enhancers | H1 Cell Line | embryonic stem cell |
6 | chr7:125413000-125413800 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
7 | chr7:125413200-125413600 | Flanking Active TSS | ES-I3 Cell Line | embryonic stem cell |
8 | chr7:125413200-125413800 | Active TSS | ES-WA7 Cell Line | embryonic stem cell |
9 | chr7:125413200-125413800 | Active TSS | H1 Derived Mesenchymal Stem Cells | ES cell derived |
10 | chr7:125413200-125414000 | Enhancers | HUES6 Cell Line | embryonic stem cell |
11 | chr7:125413400-125413600 | Flanking Active TSS | iPS-15b Cell Line | embryonic stem cell |
12 | chr7:125413400-125413800 | Enhancers | H9 Cell Line | embryonic stem cell |
13 | chr7:125413600-125413800 | Active TSS | ES-I3 Cell Line | embryonic stem cell |
14 | chr7:125413600-125413800 | Active TSS | iPS-15b Cell Line | embryonic stem cell |
15 | chr7:125413600-125413800 | ZNF genes & repeats | Pancreas | Pancrea |
16 | chr7:125413800-125421400 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
17 | chr7:125414000-125414200 | Weak transcription | Pancreas | Pancrea |
18 | chr7:125417600-125417800 | Weak transcription | H9 Cell Line | embryonic stem cell |
19 | chr7:125417800-125418000 | ZNF genes & repeats | H9 Cell Line | embryonic stem cell |
20 | chr7:125421400-125421600 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |